Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764803 · ClinicalTrials.gov registry record
3DKnee™ System vs. the MJS Knee System
A clinical trial, sponsored by Encore Medical, L.P..
- Terminated
- Registry status
- 27
- Enrollment target
NCT00764803: Clinical Trial study, sponsored by Encore Medical, L.P..
NCT00764803 is a clinical trial that was terminated before completion, run by Encore Medical, L.P.. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00764803 was terminated before completion, sponsored by Encore Medical, L.P..
- TERMINATED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System in a group of 600 patients for whom data collection is already under way.
Interventions
- DEVICE Encore 3DKnee™ system
- DEVICE Encore MJS™ Knee System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-12 |
Why NCT00764803 stopped before completion
NCT00764803 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Encore 3DKnee™ system is the first listed.
NCT00764803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00764803 about?
NCT00764803 is a clinical study titled "3DKnee™ System vs. the MJS Knee System". The purpose of this study is to compare the survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System in a group of 600 patients for whom data collection is already under way.
What is the current status of trial NCT00764803?
This trial is currently terminated. The enrollment target is 27 participants. The study started on 2008-01. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00764803?
The interventions under investigation include: Encore 3DKnee™ system (DEVICE), Encore MJS™ Knee System (DEVICE).
Who is sponsoring clinical trial NCT00764803?
This trial is sponsored by Encore Medical, L.P., which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia